Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Mitomycin C for Recurrent Urethral Stricture
NCT06232005Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mitomycin c in urethral stricture (2 arms), sponsored by Ain Shams University. Primary endpoint: Urethral stricture recurrence at 1 year. Started Jan 2022; status: completed.
02
Drugs
mitomycin c
03
Conditions
urethral stricture
Beyond the preview
Go deeper on NCT06232005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06232005.